Form D · Biotechnology

CraniUS LLC

Baltimore, MD · CIK 0001878219

Offering snapshot reported Mar 6, 2026 · SEC filing

Reported sold
$19M
Offering amount: $20M
Investors reported
49
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Feb 13, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 6, 2026Initial$19,000,000No comparison49SEC filing
May 25, 2022Amendment$19,420,000$14,070,000vs Dec 9, 202121SEC filing
Dec 9, 2021Amendment$5,350,000$4,850,000vs Sep 14, 20217SEC filing
Sep 14, 2021Amendment$500,000No comparisonNot reportedSEC filing
Aug 20, 2021Initial$500,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-575691

Source: Form D, filed Mar 6, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Oray Boston, Jr. Director
Henry Brem Director
H Brett Friedman Director
Brett Friedman Director
Chad Gordon Director
Steven Klasko Director
Michael Maglin Executive
Brian Moran Director
Joshua Scheinker Director
Elliot Stone Director
Deborah I Weidman Executive
Sharon Wolfington Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1700 Union Avenue, Ste A 1
Baltimore, MD, 21211